Amalia Leceta, Aintzane GarcĂa, Ander Sologuren, Cristina Campo
BACKGROUND: Bilastine, a non-sedating H1 -antihistamine, is indicated to treat the symptoms of allergic disorders (e.g. rhinoconjunctivitis and urticaria) in adults and adolescents and, more recently, in children. Following its marketing approval, many questions regarding the ideal use of bilastine in various clinical practice situations have been received by the Medical Information Department (MID) of Faes Farma Spain. This article is an update of a previous review, with a focus on recent clinical information on the use of bilastine in paediatric and other populations...
2021: Drugs in Context